Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2021 08:00 ET | Source: BioVie Inc.

Development of BioVie’s NE3107 Asset Featured by the American Diabetes Association

SANTA MONICA, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
June 28, 2021 08:00 ET | Source: BioVie Inc.

BioVie Added to Russell Microcap® Index

SANTA MONICA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
June 25, 2021 08:00 ET | Source: BioVie Inc.

BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®

SANTA MONICA, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
June 24, 2021 08:00 ET | Source: BioVie Inc.

BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
June 23, 2021 08:00 ET | Source: BioVie Inc.

BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKI

SANTA MONICA, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
March 11, 2021 07:00 ET | Source: BioVie Inc.

BioVie to Present at 31st Annual Oppenheimer Healthcare Conference

SANTA MONICA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
March 09, 2021 07:00 ET | Source: BioVie Inc.

BioVie Commences Patient Screening in Phase 2 Clinical Trial

SANTA MONICA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
February 19, 2021 07:00 ET | Source: BioVie Inc.

BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®

SANTA MONICA, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
October 30, 2020 08:00 ET | Source: BioVie Inc.

BioVie Interview to Air on Bloomberg International on the RedChip Money Report

SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
October 29, 2020 08:00 ET | Source: BioVie Inc.

BioVie to Participate in B. Riley Securities Liver Disease Therapeutics Day on October 29, 2020

SANTA MONICA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...

Next Page keyboard_arrow_right